Skip to content

Which Drug Can Cause Cyanide Toxicity? A Pharmacological Review

4 min read

Iatrogenic cyanide toxicity is a rare but life-threatening complication primarily associated with the administration of sodium nitroprusside. Understanding which drug can cause cyanide toxicity is crucial for clinicians in critical care settings to ensure patient safety.

Quick Summary

Sodium nitroprusside, a potent medication for hypertensive crises, is the primary drug that can cause cyanide toxicity. This overview covers its mechanism, risk factors, symptoms, diagnosis, and life-saving management strategies.

Key Points

  • Primary Drug: Sodium nitroprusside (SNP), a potent vasodilator, is the most significant medication that can cause iatrogenic cyanide toxicity.

  • Mechanism of Toxicity: SNP metabolism releases five cyanide ions per molecule, which can overwhelm the body's natural detoxification pathways, leading to cellular suffocation.

  • Major Risk Factors: High infusion rates, prolonged use, renal or hepatic impairment, and poor nutritional status dramatically increase the risk of toxicity.

  • Hallmark Symptom: The development of severe, unexplained metabolic acidosis in a patient receiving a nitroprusside infusion is a critical indicator of cyanide poisoning.

  • Alternative Sources: Amygdalin (Laetrile or "vitamin B17"), found in apricot pits and used as a discredited alternative cancer therapy, can cause fatal cyanide poisoning upon ingestion.

  • Life-Saving Antidotes: Immediate treatment with hydroxocobalamin and/or sodium thiosulfate is critical to reverse toxicity and prevent death.

  • Cellular Impact: Cyanide halts cellular respiration by binding to and inhibiting the cytochrome oxidase enzyme within mitochondria, preventing oxygen utilization.

In This Article

Introduction to Cyanide and Its Toxicity

Cyanide is a rapidly acting and potentially deadly chemical poison. It functions by inhibiting cytochrome oxidase, a critical enzyme in the mitochondrial electron transport chain. This action halts aerobic metabolism, preventing cells from using oxygen to produce adenosine triphosphate (ATP) and leading to cellular hypoxia, lactic acidosis, and, ultimately, cytotoxic death. While often associated with industrial accidents and chemical warfare, cyanide poisoning can also occur in a clinical setting as a direct result of medication administration, a condition known as iatrogenic toxicity.

The Primary Culprit: Sodium Nitroprusside

Sodium nitroprusside (SNP) is a powerful, direct-acting vasodilator administered intravenously to manage acute hypertensive emergencies and severe heart failure. Its rapid onset and short half-life allow for precise blood pressure control in critical situations.

How Sodium Nitroprusside Causes Cyanide Toxicity

The therapeutic effect of SNP comes from its breakdown, which releases nitric oxide (NO). However, this same metabolic process also releases five cyanide ions for every molecule of SNP. The body has a natural detoxification pathway where the enzyme rhodanese, primarily in the liver, converts cyanide to the much less toxic thiocyanate using a sulfur donor (like thiosulfate). When the rate of SNP infusion generates cyanide faster than the body can detoxify it, free cyanide accumulates and toxicity ensues.

Risk Factors for Nitroprusside-Induced Cyanide Toxicity

Several factors can increase a patient's risk of developing cyanide toxicity from sodium nitroprusside:

  • Infusion Rate and Duration: A high rate of infusion or prolonged infusions can increase the risk of cyanide accumulation.
  • Renal and Hepatic Impairment: Kidney dysfunction impairs the excretion of thiocyanate, while liver disease can reduce the capacity to detoxify cyanide via the rhodanese enzyme.
  • Poor Nutritional Status: Patients who are malnourished may have depleted stores of thiosulfate, the crucial sulfur donor needed for detoxification.
  • Pediatric Patients: Young children and neonates may have lower reserves of thiosulfate, making them more susceptible to toxicity.

Other Potential Drug-Related Cyanide Sources

While sodium nitroprusside is the main iatrogenic source, other substances, often used as alternative medicines, can also cause cyanide poisoning.

Amygdalin (Laetrile)

Amygdalin, sometimes incorrectly marketed as "vitamin B17" or Laetrile, is a cyanogenic glycoside found in the pits of many fruits (like apricots), raw nuts, and other plants. Promoted as an alternative cancer treatment, amygdalin has been banned by the FDA for medicinal use due to its lack of efficacy and high risk of toxicity. When ingested orally, enzymes in the small intestine hydrolyze amygdalin, releasing hydrogen cyanide. Ingesting amygdalin can release a significant amount of cyanide, and large doses can be fatal. The FDA has issued warnings about products containing apricot seeds due to the risk of fatal cyanide poisoning.

Comparison of Cyanide-Inducing Agents

Feature Sodium Nitroprusside (SNP) Amygdalin (Laetrile)
Primary Use Medically approved for hypertensive emergencies and acute heart failure. Unproven alternative cancer therapy; sold as a supplement.
Route of Exposure Intravenous infusion in a clinical setting. Primarily oral ingestion of tablets or raw kernels/seeds.
Mechanism Metabolism releases nitric oxide and five cyanide ions per molecule. Enzymatic hydrolysis in the gut releases hydrogen cyanide.
Onset Can be rapid, especially with high infusion rates. Symptoms can appear within minutes to hours after ingestion.
Regulatory Status FDA-approved medication with strict warnings. Banned by the FDA for medicinal use; sold illegally as a supplement.

Recognizing and Managing Cyanide Toxicity

Prompt recognition and treatment are critical for survival.

Symptoms of Cyanide Toxicity

Symptoms are often nonspecific and can progress rapidly. Early signs may include headache, dizziness, rapid heart rate, and shortness of breath. As toxicity worsens, patients can develop:

  • Severe Metabolic Acidosis: Unexplained high anion gap metabolic acidosis is a hallmark sign, particularly in a patient receiving SNP.
  • Cardiovascular Effects: Initial hypertension and tachycardia may be followed by hypotension, bradycardia, and cardiac arrest.
  • Neurological Effects: Confusion, agitation, seizures, and coma can occur.
  • Cherry-Red Skin: This classic but inconsistent sign results from high venous oxygen saturation because tissues cannot utilize oxygen.

Diagnosis and Treatment

Diagnosis is primarily clinical, based on the patient's history (e.g., SNP infusion) and symptoms like severe metabolic acidosis. While blood cyanide levels can confirm the diagnosis, results are often not available quickly enough to guide emergency treatment.

Treatment involves immediate discontinuation of the offending agent and administration of antidotes:

  1. Supportive Care: This includes securing the airway and providing 100% oxygen.
  2. Hydroxocobalamin: This is often the first-line antidote. It binds directly to cyanide to form cyanocobalamin (vitamin B12), which is non-toxic and excreted in the urine.
  3. Sodium Thiosulfate: This acts as a sulfur donor, enhancing the body's natural detoxification of cyanide into thiocyanate via the rhodanese enzyme. It is often given with hydroxocobalamin.
  4. Nitrites (Amyl Nitrite, Sodium Nitrite): This older treatment works by inducing methemoglobinemia. Methemoglobin binds cyanide, drawing it away from cytochrome oxidase. This is now used less frequently due to risks associated with methemoglobinemia.

Conclusion

While several substances can produce cyanide, the primary answer to which drug can cause cyanide toxicity in a modern clinical setting is sodium nitroprusside. Its use demands extreme caution, with careful monitoring for signs of toxicity, especially in high-risk patients. Clinicians must maintain a high index of suspicion for cyanide poisoning when a patient on SNP develops unexplained metabolic acidosis or neurological changes. Additionally, the public and medical professionals should be aware of the dangers of unproven remedies like amygdalin (Laetrile), which carry a significant risk of fatal cyanide poisoning. Prompt administration of antidotes like hydroxocobalamin is life-saving.

An authoritative outbound link on Sodium Nitroprusside from the National Center for Biotechnology Information.

Frequently Asked Questions

The main drug that causes iatrogenic (medically induced) cyanide toxicity is sodium nitroprusside, a potent intravenous medication used to treat hypertensive emergencies.

Sodium nitroprusside is a direct-acting vasodilator that relaxes both arteries and veins. It works by releasing nitric oxide, which lowers blood pressure very rapidly, making it useful for managing life-threatening high blood pressure (hypertensive crises).

Early signs are often nonspecific and can include headache, dizziness, confusion, anxiety, nausea, and a rapid heart rate. A key sign that clinicians watch for is the development of a severe, unexplained metabolic acidosis.

Patients receiving high doses or prolonged infusions, those with kidney or liver impairment, malnourished individuals, and young children are at the highest risk.

Yes, if recognized and treated promptly, cyanide toxicity is reversible. Treatment involves stopping the drug and administering specific antidotes like hydroxocobalamin and sodium thiosulfate.

Hydroxocobalamin is a primary antidote. It binds directly with cyanide to form the non-toxic vitamin B12 (cyanocobalamin), which is then safely excreted by the kidneys.

Yes. Laetrile (amygdalin), which is found in apricot seeds, is a cyanogenic glycoside that releases cyanide when ingested. The FDA has issued warnings about these products, as they can cause severe and even fatal cyanide poisoning.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.